Table 7.
Properties, advantages, and disadvantages of different carrier biomaterials and methods used in cell-based therapies of LSCD, explored in animal models.
Carriers/Methods | Transparency | Mechanical Strength | Elasticity | Advantages | Disadvantages |
---|---|---|---|---|---|
AM | + | ++ | +++ | Stimulates cell growth, anti-inflammation, anti-angiogenesis, proper elasticity | Limited transparency, variable quality, risk of disease transmission, limited mechanical strength, poor standardization |
Carrier-free method | N/A | N/A | N/A | Rapid adhesion, does not require preparation and standardization of membranes, does not require sutures | Possibility for detachment from the ocular surface in the early period after surgery |
Fibrin gel | ++ | +++ | +++ | Proper transparency, good bioadsorbence, easy manipulation, good mechanical strength, elasticity, degradable | Possibility for immune response, risk for disease transmission |
Nanofiber | ++ | ++++ | ++ | Good transparency, high mechanical strength, highly flexible, proper biocompatibility, easy to use, controlled shape and pore size, low cost | Limited elasticity, high cost |
N/A indicates not applicable.